Literature DB >> 20238039

The role of purinergic receptors in retinal function and disease.

Michelle M Ward1, Theresa Puthussery, Kirstan A Vessey, Erica L Fletcher.   

Abstract

Extracellular ATP acts as a neurotransmitter in the central and peripheral nervous systems. In this review, the role of purinergic receptors in neuronal signaling and bi-directional glial-neuronal communication in the retina will be considered. There is growing evidence that a range of P2X and P2Y receptors are expressed on most classes of retinal neurons and that activation of P2 receptors modulates retinal function. Furthermore, neuronal control of glial function is achieved through neuronal release of ATP and activation of P2Y receptors expressed by Müller cells. Altered purinergic signaling in Müller cells has been implicated in gliotic changes in the diseased retina and furthermore, elevations in extracellular ATP may lead to apoptosis of retinal neurons.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20238039     DOI: 10.1007/978-1-4419-1399-9_44

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  3 in total

1.  Adenosine triphosphate-induced photoreceptor death and retinal remodeling in rats.

Authors:  Kirstan A Vessey; Ursula Greferath; Felix P Aplin; Andrew I Jobling; Joanna A Phipps; Tracy Ho; Robbert U De Iongh; Erica L Fletcher
Journal:  J Comp Neurol       Date:  2014-04-03       Impact factor: 3.215

2.  Retinal glial responses to optic nerve crush are attenuated in Bax-deficient mice and modulated by purinergic signaling pathways.

Authors:  Caitlin E Mac Nair; Cassandra L Schlamp; Angela D Montgomery; Valery I Shestopalov; Robert W Nickells
Journal:  J Neuroinflammation       Date:  2016-04-28       Impact factor: 8.322

3.  Onset of microglial entry into developing quail retina coincides with increased expression of active caspase-3 and is mediated by extracellular ATP and UDP.

Authors:  María Martín-Estebané; Julio Navascués; Ana Sierra-Martín; Sandra M Martín-Guerrero; Miguel A Cuadros; María-Carmen Carrasco; José L Marín-Teva
Journal:  PLoS One       Date:  2017-08-01       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.